171 related articles for article (PubMed ID: 24257475)
1. A mutation analysis of the AGL gene in Korean patients with glycogen storage disease type III.
Ko JS; Moon JS; Seo JK; Yang HR; Chang JY; Park SS
J Hum Genet; 2014 Jan; 59(1):42-5. PubMed ID: 24257475
[TBL] [Abstract][Full Text] [Related]
2. [Molecular genetic analysis of 10 Chinese patients with glycogen storage disease type III].
Wang X; Qiu WJ; Ye J; Han LS; Zhang HW; Jiang LR; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2009 Jun; 47(6):416-20. PubMed ID: 19951465
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.
Lu C; Qiu Z; Sun M; Wang W; Wei M; Zhang X
J Hum Genet; 2016 Jul; 61(7):641-5. PubMed ID: 26984562
[TBL] [Abstract][Full Text] [Related]
4. Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations.
Aoyama Y; Ozer I; Demirkol M; Ebara T; Murase T; Podskarbi T; Shin YS; Gokcay G; Okubo M
J Hum Genet; 2009 Nov; 54(11):681-6. PubMed ID: 19834502
[TBL] [Abstract][Full Text] [Related]
5. [Mutation analysis of glycogen debrancher enzyme gene in five Chinese patients with glycogen storage disease type III].
Zhuang TF; Qiu ZQ; Wei M; Huang SZ
Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):85-8. PubMed ID: 15833157
[TBL] [Abstract][Full Text] [Related]
6. Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId.
Endo Y; Fateen E; El Shabrawy M; Aoyama Y; Ebara T; Murase T; Podskarbi T; Shin YS; Okubo M
Clin Chem Lab Med; 2009; 47(10):1233-8. PubMed ID: 19754354
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area.
Lucchiari S; Fogh I; Prelle A; Parini R; Bresolin N; Melis D; Fiori L; Scarlato G; Comi GP
Am J Med Genet; 2002 May; 109(3):183-90. PubMed ID: 11977176
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of glycogen storage disease type III.
Shen JJ; Chen YT
Curr Mol Med; 2002 Mar; 2(2):167-75. PubMed ID: 11949933
[TBL] [Abstract][Full Text] [Related]
9. A founder splice site mutation underlies glycogen storage disease type 3 in consanguineous Saudi families.
Basit S; Malibari O; Al Balwi AM; Abdusamad F; Abu Ismail F
Ann Saudi Med; 2014; 34(5):390-5. PubMed ID: 25827695
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.
Endo Y; Horinishi A; Vorgerd M; Aoyama Y; Ebara T; Murase T; Odawara M; Podskarbi T; Shin YS; Okubo M
J Hum Genet; 2006; 51(11):958-963. PubMed ID: 17047887
[TBL] [Abstract][Full Text] [Related]
11. Intron retention is among six unreported AGL mutations identified in Malaysian GSD III patients.
Abdullah IS; Teh SH; Khaidizar FD; Ngu LH; Keng WT; Yap S; Mohamed Z
Genes Genomics; 2019 Aug; 41(8):885-893. PubMed ID: 31028654
[TBL] [Abstract][Full Text] [Related]
12. Molecular and biochemical characterization of Tunisian patients with glycogen storage disease type III.
Mili A; Ben Charfeddine I; Mamaï O; Abdelhak S; Adala L; Amara A; Pagliarani S; Lucchiarri S; Ayadi A; Tebib N; Harbi A; Bouguila J; H'Mida D; Saad A; Limem K; Comi GP; Gribaa M
J Hum Genet; 2012 Mar; 57(3):170-5. PubMed ID: 22089644
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the AGL gene: five novel mutations in GSD III patients.
Lucchiari S; Donati MA; Melis D; Filocamo M; Parini R; Bresolin N; Comi GP
Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955720
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III.
Oh SH; Park HD; Ki CS; Choe YH; Lee SY
Clin Chem Lab Med; 2008; 46(9):1245-9. PubMed ID: 18785866
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan.
Okubo M; Horinishi A; Takeuchi M; Suzuki Y; Sakura N; Hasegawa Y; Igarashi T; Goto K; Tahara H; Uchimoto S; Omichi K; Kanno H; Hayasaka K; Murase T
Hum Genet; 2000 Jan; 106(1):108-15. PubMed ID: 10982190
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL.
Lucchiari S; Donati MA; Parini R; Melis D; Gatti R; Bresolin N; Scarlato G; Comi GP
Hum Mutat; 2002 Dec; 20(6):480. PubMed ID: 12442284
[TBL] [Abstract][Full Text] [Related]
17. A c.3216_3217delGA mutation in AGL gene in Tunisian patients with a glycogen storage disease type III: evidence of a founder effect.
Mili A; Ben Charfeddine I; Amara A; Mamaï O; Adala L; Ben Lazreg T; Bouguila J; Saad A; Limem K; Gribaa M
Clin Genet; 2012 Dec; 82(6):534-9. PubMed ID: 22035446
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of amyloglucosidase mutations in Asian Indian patients with Glycogen storage disease type III.
Perveen S; Gupta N; Kumar M; Kaur P; Chowdhury MR; Kabra M
Am J Med Genet A; 2020 May; 182(5):1190-1200. PubMed ID: 32222031
[TBL] [Abstract][Full Text] [Related]
19. Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III.
Horinishi A; Okubo M; Tang NL; Hui J; To KF; Mabuchi T; Okada T; Mabuchi H; Murase T
J Hum Genet; 2002; 47(2):55-9. PubMed ID: 11924557
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of Egyptian patients with glycogen storage disease type IIIa.
Endo Y; Fateen E; Aoyama Y; Horinishi A; Ebara T; Murase T; Shin YS; Okubo M
J Hum Genet; 2005; 50(10):538-542. PubMed ID: 16189622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
